Compare ZBH & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZBH | AFRM |
|---|---|---|
| Founded | 1927 | 2012 |
| Country | United States | United States |
| Employees | 17000 | 2206 |
| Industry | Industrial Specialties | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 19.6B |
| IPO Year | N/A | 2021 |
| Metric | ZBH | AFRM |
|---|---|---|
| Price | $89.80 | $56.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 21 | 27 |
| Target Price | ★ $107.30 | $87.67 |
| AVG Volume (30 Days) | 2.3M | ★ 6.3M |
| Earning Date | 02-10-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.08% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.03 | 0.76 |
| Revenue | ★ $8,010,900,000.00 | $3,715,908,000.00 |
| Revenue This Year | $7.98 | $28.46 |
| Revenue Next Year | $4.91 | $25.04 |
| P/E Ratio | ★ $22.00 | $77.79 |
| Revenue Growth | 5.47 | ★ 32.70 |
| 52 Week Low | $84.59 | $30.90 |
| 52 Week High | $114.44 | $100.00 |
| Indicator | ZBH | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 32.88 |
| Support Level | $85.76 | $58.12 |
| Resistance Level | $90.00 | $64.62 |
| Average True Range (ATR) | 1.94 | 3.33 |
| MACD | 0.34 | -1.07 |
| Stochastic Oscillator | 73.11 | 13.11 |
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm primarily operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.